DSN, higi introduce first-ever Fit Pharmacist Challenge

Drug Store News, in partnership with higi, is hosting the first-ever Fit Pharmacist Challenge, a series of fitness-tracking competitions that will reward winning pharmacists and pharmacy technicians. Read more ...

Parody infomercial hammers home anti-smoking message

Action on Smoking & Health recently launched an infomercial campaign behind its new faux product, The Wrinkler, which purports to add between 10 and 20 years of aging to a users face. Read More ...

Field Agent offers up key allergy insights in latest survey

More than four in five consumers are planning on turning to the allergy aisle for relief of congestion or sneezing due to their allergies this year. Read More ...

NABP announces general registration date for .pharmacy domains

Some online pharmacy sites will soon be able to point visitors to their .pharmacy domain names. Read More ...

Current news

Teva announced Monday that it had launched its generic version of Actonel in 5-, 30- and 35-mg dosage strengths.
What does the annual allergy season and the New York Knicks have in common? Every subsequent year, they both experience their worst season ever.
Your phone can tell you the weather, the latest stock reports, sync your email and send you calendar reminders, and now with Fertility Friend, women can use their phones to monitor ovulation cycles.
Pharmacists caring for underserved patients with suboptimally controlled type 2 diabetes were more adherent to their medications and had better glycemic control than those who did not have a pharmacist in their care team, according to a recent report.
Recognizing that onsite health facilities can be an integral component of a successful health care program, employers are seeking to expand their use of such centers in the coming years, according to new research by global professional services company Towers Watson.
The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM).
Teva on Friday announced that it would be rolling out Junel Fe 24, a generic version of Lomedia 24 Fe birth control bills.
The U.S. Food and Drug Administration approved two treatments for Irritable Bowel Syndrome with Diarrhea (IBS-D) on Wednesday. Both Patheon Pharmaceuticals’ Viberzi (eluxadoline) and Salix Pharmaceuticals’ Xifaxan (ritaximin) are now available to patients.
Action on Smoking & Health recently launched an infomercial campaign behind its new faux product, The Wrinkler, which purports to add between 10 and 20 years of aging to a users face.
On Thursday Roxane Laboratories announced that its alosetron hydrochloride tablets — a generic version of irritable bowel syndrome treatment Lotronex — was available in 0.5- and 1-mg strength.

CPE Monitor Reminders

As of May 1, 2014, ACPE-accredited CE Providers, such as Drug Store News, may no longer issue statements of credit. All credit awarded by ACPE-accredited providers to pharmacists and pharmacy technicians must be via CPE Monitor. Any statements obtained from the Drug Store News website are no longer valid statements of credit. You MUST obtain your statement of credit from CPE Monitor at MyCPEMonitor.net.

Please be sure that you enter your correct NABP e-PID number in your Drug Store News CE profile. This ensures your CE credit will be transmitted to CPE Monitor so you may receive credit for completed CPE activities. To look up your e-PID number go to the MyCPEMonitor.net or NABP.net site and search the system for their NABP e-PID number.